Online citations, reference lists, and bibliographies.
← Back to Search

Dynamic And Cellular Interactions Of Nanoparticles In Vascular-targeted Drug Delivery (review)

R. B. Huang, Supriya Mocherla, M. Heslinga, P. Charoenphol, O. Eniola-Adefeso
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract Vascular-targeted drug delivery systems could provide more efficient and effective pharmaceutical interventions for treating a variety of diseases including cardiovascular, pulmonary, inflammatory, and malignant disorders. However, several factors must be taken into account when designing these systems. The diverse blood hemodynamics and rheology, and the natural clearance process that tend to decrease the circulation time of foreign particles all lessen the probability of successful carrier interaction with the vascular wall. An effective vascular-targeted drug delivery system must be able to navigate through the bloodstream while avoiding immune clearance, attach to the vascular wall, and release its therapeutic cargo at the intended location. This review will summarize and analyze current literature reporting on (1) nanocarrier fabrication methods and materials that allow for optimum therapeutic encapsulation, protection, and release; (2) localization and binding dynamics of nanocarriers as influenced by hemodynamics and blood rheology in medium-to-large vessels; (3) blood cells' responses to various types of nanocarrier compositions and its effects on particle circulation time; and (4) properties that affect nanocarrier internalization at the target site.
This paper references
10.1073/PNAS.0600997103
Role of target geometry in phagocytosis.
J. Champion (2006)
10.1161/01.ATV.8.6.819
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood.
P. Aarts (1988)
10.1007/S10544-007-9136-5
Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI)
Bryan R. Smith (2008)
10.1002/anie.200806241
Multicompartmental microcylinders.
S. Bhaskar (2009)
10.1016/J.COLSURFB.2004.05.007
Interaction of PLGA nanoparticles with human blood constituents.
D. Kim (2005)
10.1073/pnas.0914585107
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
J. M. Chan (2010)
10.1016/j.jconrel.2009.03.017
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles.
M. Kilpeläinen (2009)
Nanomedicine, nanotoxicology: two sides of the same coin
VE Kagan (2005)
10.1021/mp8000292
The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers.
Jongdoo Lim (2008)
10.1016/j.tox.2009.08.011
Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation.
P. Bihari (2010)
10.1073/pnas.0805135105
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
10.1016/j.biomaterials.2009.10.046
The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
Q. He (2010)
10.1016/J.YGYNO.2004.03.024
Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
D. Uyar (2004)
10.1021/ja801631c
Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer.
Yu Cheng (2008)
10.1089/10430340152712683
The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid.
J. N. Higginbotham (2002)
10.1016/j.jneuroim.2009.03.015
Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection
L. Shriver (2009)
10.1158/1535-7163.MCT-05-0161
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
M. Backer (2005)
10.1007/978-0-387-76713-0_9
Liposomes in biology and medicine.
R. Schwendener (2007)
10.1016/J.CHEMBIOL.2006.11.015
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
Seungpyo Hong (2007)
10.1529/BIOPHYSJ.104.057729
I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow.
A. O. Eniola (2005)
10.1042/BJ20031253
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
10.1016/j.bbamem.2009.06.022
Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.
Shyh-Dar Li (2009)
10.1007/s00441-008-0676-7
Targeted delivery of therapeutics to endothelium
E. Simone (2008)
Atherosclerosis and cancer: common molecular pathways of disease development and progression.
J. Ross (2001)
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
F. Yuan (1995)
10.1016/j.biomaterials.2009.08.008
Antiangiogenic properties of silver nanoparticles.
S. Gurunathan (2009)
10.1006/TAAP.2001.9240
Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines.
D. Brown (2001)
10.1201/b13999
Inflammatory Diseases of Blood Vessels
G. Hoffman (2001)
10.1016/J.CBI.2007.01.015
Nanoconjugate based on polymalic acid for tumor targeting.
J. Ljubimova (2008)
The release of in fl ammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants , capsid
JN Higginbotham (2002)
10.1038/SJ.MT.6300323
Tumor-targeted delivery of siRNA by self-assembled nanoparticles.
Shyh-Dar Li (2008)
10.1002/jgm.696
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
A. Akinc (2005)
10.1007/s12282-008-0037-0
In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine
M. Takeda (2008)
10.1158/0008-5472.CAN-06-2354
Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
W. Lu (2006)
Gold nanoparticles and a microscopic view of platelets: a preliminary observation.
V. Wiwanitkit (2009)
10.1073/PNAS.92.16.7297
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
O. Boussif (1995)
10.1021/bm900128x
Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae.
Takehiro Nishikawa (2009)
Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.
L. Fenart (1999)
10.1152/AJPLUNG.00533.2005
Endocytosis pathways in endothelium: how many?
R. Stan (2006)
10.1016/S1359-6446(04)03276-3
Dendrimers and dendritic polymers in drug delivery.
E. Gillies (2005)
10.1158/1078-0432.CCR-06-0946
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
G. R. Reddy (2006)
10.1016/j.bbamem.2007.12.021
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo.
S. Gosk (2008)
10.1016/j.jconrel.2009.01.021
Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Y. Patil (2009)
10.1007/s10571-010-9496-x
Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood–Brain Barrier In Vitro
P. Wang (2010)
10.1002/JPS.20999
Mesoporous silicon in drug delivery applications.
J. Salonen (2008)
10.1016/j.jconrel.2009.05.020
Fabrication of biodegradable spheroidal microparticles for drug delivery applications.
M. Heslinga (2009)
10.1021/JA051977C
Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials.
J. Rolland (2005)
10.1182/BLOOD-2004-05-1714
ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs.
S. Muro (2005)
10.1021/NL052396O
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.
B. Chithrani (2006)
10.1038/nnano.2007.70
Shape effects of filaments versus spherical particles in flow and drug delivery.
Y. Geng (2007)
10.1038/nmat2398
Biodegradable luminescent porous silicon nanoparticles for in vivo applications.
J. Park (2009)
10.1016/J.YMTHE.2005.03.038
Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes.
J. Rejman (2005)
10.1126/SCIENCE.284.5417.1143
Polymersomes: tough vesicles made from diblock copolymers.
B. Discher (1999)
10.1016/S0168-3659(01)00215-2
Targeting of superoxide dismutase and catalase to vascular endothelium.
V. Muzykantov (2001)
10.1111/j.1749-6632.2000.tb06318.x
Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a
M. Gimbrone (2000)
10.1038/nrm2751
Tickets to ride: selecting cargo for clathrin-regulated internalization
L. Traub (2009)
10.2741/1603
The induction of inflammation by adenovirus vectors used for gene therapy.
M. J. Cotter (2005)
10.1186/1477-3155-6-9
The margination propensity of spherical particles for vascular targeting in the microcirculation
F. Gentile (2008)
10.1021/mp800051m
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
10.1016/j.biomaterials.2009.01.019
The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.
R. Serda (2009)
10.1016/j.biomaterials.2009.03.054
The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood.
K. Stevens (2009)
10.1021/ja803036e
Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device.
S. Dhar (2008)
10.1016/0142-9612(89)90101-4
Platelet aggregation induced by latex particles. I. Effects of size, surface potential and hydrophobicity of particles.
M. Miyamoto (1989)
10.1016/S0168-3659(01)00504-1
pH-sensitive polymers that enhance intracellular drug delivery in vivo.
T. Kyriakides (2002)
10.1016/j.jconrel.2009.09.032
The hydrogel template method for fabrication of homogeneous nano/microparticles.
G. Acharya (2010)
10.1023/B:JMSM.0000021095.36878.1B
Effects of nano-scaled particles on endothelial cell function in vitro: Studies on viability, proliferation and inflammation
K. Peters (2004)
10.1016/j.addr.2008.03.017
Porous silicon in drug delivery devices and materials.
E. Anglin (2008)
10.3181/0706-RM-165
The Acute Proinflammatory and Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats
A. Nemmar (2008)
Endothelial dysfunction, hemodynamic forces
M A Gimbrone (2000)
10.1089/ars.2008.2028
Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways.
P. Buehler (2008)
10.1016/J.BIOELECHEM.2003.09.023
Influence of PAMAM dendrimers on human red blood cells.
D. Domański (2004)
10.1161/CIRCULATIONAHA.106.684738
Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1
B. Kaufmann (2007)
10.1038/mt.2008.127
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.
S. Muro (2008)
10.1089/cbr.2008.0515
Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
Xiao-wen He (2009)
Blood platelets are concentrated near the wall, red blood cells
P A Aarts (1988)
10.2217/17435889.3.4.507
Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death.
Youngnam Cho (2008)
10.1073/pnas.0801763105
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
10.1371/journal.ppat.1000417
Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin
Kristopher J. Koudelka (2009)
10.1196/annals.1302.031
Dynamics of Blood Flow and Platelet Transport in Pathological Vessels
S. Einav (2004)
10.1007/S10544-007-9081-3
Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI)
Bryan R. Smith (2007)
10.1016/S0142-9612(01)00349-0
Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes.
A. O. Eniola (2002)
10.1002/CHEM.200600594
Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications.
J. F. Bermejo (2007)
10.1016/J.BIOMATERIALS.2007.04.047
Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells.
C. Wilhelm (2007)
10.1182/blood-2008-01-078204
The vessel wall and its interactions.
D. Wagner (2008)
Silicon and bone health.
R. Jugdaohsingh (2007)
Nutrition, rheumatic disease (nutrition, health)
L. Coleman (2008)
10.1002/ceat.200800176
Purification of Bionanoparticles
L. Pedro (2008)
10.1021/nn900277t
Characterization of antiplatelet properties of silver nanoparticles.
Siddhartha S Shrivastava (2009)
10.1016/J.BBAMEM.2006.12.013
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
N. Dos Santos (2007)
10.1016/J.IJPHARM.2007.06.023
Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.
Y. Jallouli (2007)
10.1016/J.EJPB.2007.09.021
In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome.
A. Vargas (2008)
10.1211/jpp.58.11.0010
Investigations on the toxicological profile of functionalized fifth‐generation poly(propylene imine) dendrimer
H. Agashe (2006)
10.1002/JBM.A.30879
Biocompatibility of poly(ether)urethane-gold nanocomposites.
S. Hsu (2006)
10.1073/pnas.0903369106
Targeting atherosclerosis by using modular, multifunctional micelles
D. Peters (2009)
10.1016/J.BIOMATERIALS.2007.09.023
Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.
T. Dziubla (2008)
10.1016/J.ADDR.2006.09.014
Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging.
M. Manchester (2006)
10.1038/nnano.2008.34
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.
E. Tasciotti (2008)
10.1016/j.jbiomech.2009.05.012
Design of bio-mimetic particles with enhanced vascular interaction.
Sei-Young Lee (2009)
10.1016/J.EJPS.2005.08.002
In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Chao Fang (2006)
10.3109/10611860108997929
Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro
R. N. Alyaudtin (2001)
10.1016/j.biomaterials.2010.01.006
Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.
Megan M. Kaneda (2010)
10.1016/j.biomaterials.2008.04.030
Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.
Kathryn Partlow (2008)
Platelet activation, atherothrombosis
G Davi (2007)
10.1016/J.BIOMATERIALS.2006.11.028
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
10.1016/j.jconrel.2009.03.002
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
Anja Zensi (2009)
10.1007/s11095-005-4590-3
Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies
Goldie Kaul (2005)
10.1007/s11095-006-9219-7
Optical Imaging of the Adoptive Transfer of Human Endothelial Cells in Mice Using Anti-Human CD31 Monoclonal Antibody
A. Bogdanov (2006)
10.1021/bm900189x
Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase.
Eric A Simone (2009)
10.1016/j.jconrel.2009.09.030
How to study dendriplexes II: Transfection and cytotoxicity.
D. Shcharbin (2010)
10.1002/(SICI)1097-0290(20000120)67:2<217::AID-BIT11>3.0.CO;2-Q
Design of imidazole-containing endosomolytic biopolymers for gene delivery.
D. Pack (2000)
10.2147/TCRM.S5148
Pegylated liposomal doxorubicin in ovarian cancer
R. Strother (2009)
10.1016/J.JCONREL.2006.11.020
Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
I. Kratzer (2007)
10.1016/j.nano.2008.12.002
Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.
R. Southworth (2009)
10.1007/s11095-008-9697-x
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
P. Decuzzi (2008)
10.1080/10611860290031877
Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier
J. Kreuter (2002)
10.1002/smll.200700595
Cytotoxicity of nanoparticles.
Nastassja Lewinski (2008)
10.1016/j.tox.2009.01.015
The role of nanoparticle size in hemocompatibility.
A. Mayer (2009)
10.1074/jbc.M308643200
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*
N. D. Sonawane (2003)
PAMAM dendrimers for brain delivery of therapeutics for the treatment of cerebral palsy: chemistry, in vivo efficacy, imaging
R Kannan (2009)
10.1016/J.BBAMCR.2005.11.007
Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers.
M. Kirkham (2005)
10.1083/JCB.27.3.531
PLATELET PHAGOCYTOSIS AND AGGREGATION
H. Movat (1965)
10.1016/j.tcm.2006.01.003
Vascular Targeting: Recent Advances and Therapeutic Perspectives
A. Hajitou (2006)
10.1007/s11095-005-7247-3
Immunoliposomes Directed Toward VCAM-1 Interact Specifically with Activated Endothelial Cells—A Potential Tool for Specific Drug Delivery
M. Voinea (2005)
10.1021/BC700212B
Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets.
JunMin Zhu (2007)
10.1021/mp700086j
Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.
R. S. Dhanikula (2008)
10.1016/J.JCONREL.2007.05.027
Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.
Stephanie E. A. Gratton (2007)
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
P. Winter (2006)
10.1016/j.biomaterials.2009.08.049
Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Weilun Ke (2009)
10.1073/pnas.0803728105
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
E. Murphy (2008)
10.1002/352760006X.CH7
Vascular Endothelium in Inflamed Tissue as a Target for Site Selective Delivery of Drugs
M. Everts (2001)
10.1016/j.addr.2008.08.005
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
10.1200/JCO.2001.19.14.3312
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.
A. Gordon (2001)
10.1021/mp800176t
Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
G. Jiang (2009)
10.1016/0267-6605(94)90061-2
In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging.
C. Chouly (1994)
10.1016/J.IJPHARM.2005.01.043
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
W. Lu (2005)
10.1007/s11095-006-9223-y
Functionalized Micellar Systems for Cancer Targeted Drug Delivery
Damon M Sutton (2006)
10.1002/jbm.a.32549
In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
R. Srinivasan (2010)
10.1021/la901419w
Polymerization of hydrogels inside self-assembled block copolymer vesicles.
Jeffery Gaspard (2009)
10.1038/sj.bjp.0706386
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Anna Radomski (2005)
10.1016/J.JCIS.2006.04.052
The adsorption of hyperbranched polymers on silicon oxide surfaces.
Sedat Ondaral (2006)
10.1016/S0006-3495(96)79248-2
Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation.
L. Munn (1996)
10.1152/AJPHEART.2000.279.4.H1460
Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery.
M. J. Pearson (2000)
10.1016/S0168-3659(03)00201-3
Polymer vesicles in vivo: correlations with PEG molecular weight.
P. Photos (2003)
10.1615/CRITREVEUKARGENEEXPR.V16.I4.10
Vascular and cellular targeting for photodynamic therapy.
B. Chen (2006)
10.1016/J.ADDR.2007.06.008
Endocytic mechanisms for targeted drug delivery.
Lisa Bareford (2007)
10.1021/bm700535p
Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells.
Oshrat Harush-Frenkel (2008)
10.1016/j.colsurfb.2008.07.004
Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
Ganeshchandra Sonavane (2008)
10.1073/pnas.2631433100
Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo
Harshad S. Sakhalkar (2003)
10.1021/BC700227Z
PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.
N. Zhang (2008)
10.1021/ja902039y
Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery.
J. Liu (2009)
10.1016/S0006-3495(02)73948-9
Red blood cells augment leukocyte rolling in a virtual blood vessel.
C. Migliorini (2002)
10.1016/j.jconrel.2009.10.014
Size and shape effects in the biodistribution of intravascularly injected particles.
P. Decuzzi (2010)
10.1021/la902390d
Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface.
Yu Cheng (2010)
Hydrodynamic interaction between erythrocytes and leukocytes affects rheology of blood in microvessels.
Vijay Pappu (2007)
10.1088/0957-4484/20/49/495101
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows.
Sei-Young Lee (2009)
10.1160/TH09-03-0192
Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
L. Jennings (2009)
10.1016/j.biomaterials.2009.11.007
Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers.
P. Charoenphol (2010)
10.1073/pnas.0705326104
Making polymeric micro- and nanoparticles of complex shapes
J. Champion (2007)
10.1016/0026-2862(88)90036-2
Conditions for the occurrence of large near-wall excesses of small particles during blood flow.
E. Eckstein (1988)
10.1021/BC010053L
A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex.
C. Lackey (2002)
10.1002/SMLL.200700054
Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging.
X. Shi (2007)
10.1016/S0928-8244(03)00033-6
HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro.
H. Langeggen (2003)
10.1016/S0735-1097(98)00607-X
In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement.
S. Demos (1999)
10.1007/s11095-005-7547-7
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
J. Koziara (2005)
10.1152/AJPHEART.00408.2002
Rheological properties of the blood influencing selectin-mediated adhesion of flowing leukocytes.
K. Abbitt (2003)
10.1073/pnas.0608582104
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
T. Cedervall (2007)



This paper is referenced by
10.1055/s-0036-1597767
The Future of Nanoparticle-Directed Venous Therapy.
B. Jacobs (2017)
10.1007/s11095-016-1902-8
Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells
H. Xu (2016)
10.1016/j.biomaterials.2013.04.011
The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow.
A. Thompson (2013)
10.1016/j.biomaterials.2011.10.077
ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.
S. Crayton (2012)
10.1016/j.atherosclerosis.2011.04.016
Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters.
P. Charoenphol (2011)
10.1016/j.colsurfb.2017.07.085
Immunoliposomes: A review on functionalization strategies and targets for drug delivery.
Josimar O. Eloy (2017)
10.1007/s11095-014-1353-z
Development of High-Content Gemcitabine PEGylated Liposomes and Their Cytotoxicity on Drug-Resistant Pancreatic Tumour Cells
H. Xu (2014)
10.1021/nn500136z
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
Melissa D. Howard (2014)
10.1021/nn300415x
Molecular interaction of proteins and peptides with nanoparticles.
A. Shemetov (2012)
10.1134/S1995078013060116
Structural and functional aspects of the interaction of proteins and peptides with nanoparticles
K. A. Rumyantsev (2013)
10.3791/52162
Non-invasive Parenchymal, Vascular and Metabolic High-frequency Ultrasound and Photoacoustic Rat Deep Brain Imaging
P. Giustetto (2015)
10.1021/acs.chemrev.5b00135
Polymeric Nanostructures for Imaging and Therapy.
Mahmoud Elsabahy (2015)
10.1016/j.biomaterials.2011.08.067
Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery.
Christa L. Modery (2011)
10.1016/j.addr.2015.10.011
Non-affinity factors modulating vascular targeting of nano- and microcarriers.
J. Myerson (2016)
Semantic Scholar Logo Some data provided by SemanticScholar